New Topical Pipeline Reviews by Global Markets Direct Recently Published at MarketPublishers.com04 Jul 2011 • by Natalie Aster
LONDON - Market Publishers Ltd informs that new in-demand Global Markets Direct pipeline reviews on various diseases have been added to its catalogue.
Each report provides an overview of the respective disease’s therapeutic pipeline. Each review presents information on the therapeutic development for the analyzed disease, complete with latest updates, and special features on late-stage and discontinued projects. Key players involved in the therapeutic development for the pertinent disease are also addressed in each study.
The scope of each pipeline review comprises:
- A snapshot of the global therapeutic scenario for the respective analyzed disease;
- A review of the respective disease’s products under development by companies and universities/research institutes based on information derived from company and industry-specific sources;
- Coverage of products based on various stages of development ranging from discovery till registration stages;
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics;
- Coverage of the respective disease’s pipeline on the basis of therapeutic class, route of administration and molecule type;
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research and development progress;
- Key discontinued pipeline projects;
- Latest news and deals relating to the products.
The list of new reviews incorporates:
- Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, Q2 2011
- Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – Q1 2011
- Addiction - Pipeline Review, Q2 2011
- Adrenoleukodystrophy - Pipeline Review, Q2 2011
- Abscess - Pipeline Review, Q2 2011
- Behcet's Disease - Pipeline Review, Q2 2011
- Islet cell carcinoma (Neuroendocrine Tumors) - Pipeline Review, Q2 2011
- iBio, Inc. – Product Pipeline Review – Q1 2011
- Exanthema - Pipeline Review, Q2 2011
- HRA Pharma, SA – Product Pipeline Review – Q1 2011
- Ependymoma - Pipeline Review, Q2 2011
- Dynavax Technologies Corporation – Product Pipeline Review – Q1 2011
- Santaris Pharma A/S – Product Pipeline Review – Q1 2011
- Muscle Spasm - Pipeline Review, Q2 2011
- Primitive Neuroectodermal Tumor - Pipeline Review, Q2 2011
More new reviews by Global Markets Direct can be found at https://marketpublishers.com/members/globalmarketsdir/info.html
The Market Publishers, Ltd.
Tel: +44 208 123 2220
Fax: +44 207 900 3970